Nohla has raised a total of $111 million toward improving the use of umbilical cord blood instead of bone marrow in stem-cell transplants to treat cancer and other diseases.
Seattle Biz Journal
Nohla adds million in funding and three new investors
Nohla has raised a total of $111 million toward improving the use of umbilical cord blood instead of bone marrow in stem-cell transplants to treat cancer and other diseases.
Seattle Biz Journal
Nohla adds million in funding and three new investors